Long arginine 3-IGF-1, abbreviated as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1).[1][2] It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence (arginine 3), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) (long), for a total of 83 amino acids (relative to the 70 of IGF-1).[2] The consequences of these modifications are that IGF-1 LR3 retains the pharmacological activity of IGF-1 as an agonist of the IGF-1 receptor, has very low affinity for the insulin-like growth factor-binding proteins (IGFBPs), and has improved metabolic stability.[1][2] As a result, it is approximately three times more potent than IGF-1,[3] and possesses a significantly longer half-life of about 2030 hours (relative to IGF-1s half-life of about 1215 hours).[4] IGF-1 LR3 Peptide is under active investigation in a number of cell culture and animal models
It also has the lowest energy and maintenance costs
Without adequate intrinsic factors, the body cannot effectively metabolize B12 and deficiencies will occur over time
The common side effects, why they happen, how long they last, how to manage nausea, the warning signs, and how supervision keeps them minimal, from a clinic in Doral
Barnill My wife received her Pfizer vaccine on 3/26 and has similar numbness to yours, but no brain fog
Because long-term reproductive studies remain limited, most providers recommend avoiding peptide therapy during: Patients attempting to conceive should discuss all medications, supplements, and peptide therapies with their healthcare provider
